Glaxo Names New China, Asia Business Heads Two Years After Probe - (Bloomberg via NewsPoints Desk)

  • GlaxoSmithKline named Thomas Willemsen, currently head of China pharmaceuticals commercial operations, as general manager for pharmaceuticals and vaccines in the country, Bloomberg reported.

  • Willemsen will succeed Herve Gisserot, who led the company's recovery after a Chinese government probe into the drugmaker's sales practices that ended with a 3 billion yuan ($437 million) fine in 2014.

  • Meanwhile, Gisserot will become head of pharmaceuticals for the Asia Pacific region, and will continue to report to Abbas Hussain, president of global pharmaceuticals at GlaxoSmithKline.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.